What changed and what caused harm
Retatrutide effects in Phase 2 studies and personal reports
Eli Lilly made retatrutide to curb hunger and help blood sugar. Studies found benefits and harm. Personal reports can't prove either one.
Study findings give firmer answers than online reports
Eli Lilly first tested retatrutide in small groups. Phase 2, the wider test of benefits and harm, led to Phase 3.
The drug hasn't been approved for sale or prescription. Lawful access as a medicine is confined to authorized clinical trials.
Measured changes come first: weight, pulse, liver fat, and blood sugar. All came from Phase 2.
Next come posts from people who used research-labeled material. Those stories aren't checked medical facts.
No controlled study tested the online claims. You also can't know whether each vial held real retatrutide.
The last section explains the chief harm found in studies. You won't find dose advice or use steps here.
A personal post can't show what's safe for you. Study averages can't foretell your response.
Phase 2 found less weight, lower sugar, and faster pulses
Weight changed the most. A 48-week Phase 2 study followed adults with obesity [1]. At 12 mg, their average loss was 24.2%.
At 8 mg, the average was 17.3%. The 4 mg group lost 8.7%, while the 1 mg group lost 1.6%.
The placebo group received an injection with no retatrutide and lost 2.1%. Weight was still falling when week 48 ended.
The three-month blood-sugar test improved too. This test shows your average blood sugar over that time. Adults with type 2 diabetes took part in Phase 2 [2].
At 12 mg, the test fell 2.02 points after 24 weeks. Lower is better, but your doctor sets your goal.
The placebo result fell 0.01 point. A 2026 review also found that this test improved in Phase 2 [15].
That review combined results in another way. It showed a fall, but not whether each person reached a healthy goal.
Liver fat also fell sharply. At 12 mg, the average fell 82.4% by week 24 [5]. A scan found normal liver fat in 86% of that group.
The study called a result below 5% normal. The fall was still 86.0% at 12 mg in week 48.
The study found a higher resting pulse. The largest rise came near week 24 [1]. This was a study finding, not an online guess.
Your result might not match the group. An average can't tell you what yours would be.
Online users describe changes that studies haven't tested
People using research-labeled retatrutide made these claims online. Controlled studies didn't test the claims, so they aren't study findings.
The posts don't come with checked amounts or checked vials. What you feel could differ from every report.
People often say hunger fades. Some describe fewer unwanted thoughts about food. Food seems to fill less of the day.
They call those thoughts "food noise." That's a personal phrase, not a study result.
People often say weight drops fast. Some report scale changes within the first several weeks. Their posts don't prove retatrutide caused the loss.
A Phase 2 study did find large weight loss. Phase 1 was an early safety test, and those later posts weren't part of it.
Study results and online posts aren't equal proof. Neither one can tell what will happen in your body.
Some people feel warmer. They mention mild flushing, more sweat, or running warm. Retatrutide may turn stored fat into energy faster.
No controlled study tied that action to feeling warm. You can't tell how often the feeling truly occurs.
Some people report a better mood. Some worried less about food. Other people said eating filled less of the day.
A study hasn't shown that retatrutide lifts mood. These posts only tell you what someone felt.
Nausea comes up often. Some felt sick 4–8 hours after a shot. They said it was worst early on or when the amount rose.
Most said nausea eased with time. In Phase 2, nausea reached 45% at the highest amount.
A faster pulse appears in some posts. Some watches showed rises of 5–15 beats per minute. The change seemed largest after a shot.
Phase 2 also found a rise in pulse. That study result doesn't prove each online post.
Some report sulfur-smelling belches. Food may stay in the stomach longer. A post can't prove why belching occurred.
Tiredness is another common report. People mention heavy legs or needing more sleep. The feeling often came soon after a shot.
Some people report constipation. They had fewer bowel movements while eating much less. A post can't tell which change caused it.
Skin itching was less common. Some saw mild redness around the injection spot. It cleared within 24–48 hours in those posts.
Study teams recorded skin reactions in about 8% of Phase 2 participants. That study count is firmer than a post.
Some people had poor sleep. Some couldn't get to sleep or stay asleep. Reports placed this most often early on.
Fast loss can include muscle. Some people said their bodies felt softer as weight fell. Phase 2 tests found losses of fat and muscle.
Age can make muscle loss more serious. Strong muscles help you rise, walk, and keep your balance.
An online story may sound like your case. You still can't know whether that person's health or vial matched yours.
Studies found nausea, faster pulses, and muscle loss
A vial bought online may be false or dirty. Retatrutide wasn't approved by mid-2026. You can't confirm its contents or strength outside a study.
A vial may also carry germs or other matter. Germs in a shot can cause a grave infection.
During 2025, the FDA mailed over 50 warning letters. Those letters named sellers that broke federal drug law.
Higher Phase 2 amounts brought more stomach trouble. Nausea reached 45% at the highest dose [1]. Nausea, vomiting, and diarrhea caused many of the 18% dropouts.
A gut hormone copied by retatrutide keeps food in your stomach longer. Vomiting or diarrhea can drain needed water and salts.
Without close care, that can make you quite ill. Your own doctor can check for such harm.
Higher amounts also brought a faster pulse in Phase 2. At the highest doses, resting pulse rose about 5–7 beats per minute [1]. The largest rise appeared around week 24.
A study of heart and kidney harm is still running [10]. It hasn't shown whether long use harms the heart.
Low blood sugar can be dangerous. The risk can rise with insulin or some diabetes pills [2]. Retatrutide also tells the body to release insulin.
Phase 2 staff lowered insulin for some people already taking it. That finding shows why close medical care mattered.
You can't safely copy such a change at home. Your health and other drugs may differ.
Fast weight loss can take muscle too. A 2025 study found that in people with type 2 diabetes [14]. They lost fat and muscle.
For an older person, lost muscle isn't a small matter. You need muscle for walking, stairs, and balance.
Long use still has open questions. Phase 1 checked short-term safety. Phase 1 couldn't settle years of harm.
Phase 1 led to Phase 2, which has finished. Phase 1/2/3 means the full test path; only the last stage still ran in 2026.
We don't yet have long-term results. With other hunger drugs, weight often returned after people stopped.
That doesn't tell us what retatrutide will do. Tell your doctor about new nausea or pulse changes.
Another person's story can't show how much danger you face.